Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free BIIB Stock Alerts

Biogen (BIIB) News Today

Biogen logo
$212.50 -8.33 (-3.77%)
Closing price 09/8/2026 04:00 PM Eastern
Extended Trading
$214.36 +1.86 (+0.88%)
As of 09/8/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Biogen Latest News

Register Now: Limited Seating Remains for HMG Strategy’s Sept. 10 Boston C-Level Technology Leadership Summit
September 8 at 2:31 PM  |  finance.yahoo.comhttps://finance.yahoo.com/technology/articles/register-now-limited-seating-remains-143000671.html
Lilly Builds Neuroscience into a New Long-Term Growth Driver
September 8 at 9:30 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/lilly-builds-neuroscience-long-term-122700438.html
Saudi Central Bank Increases Stock Holdings in Biogen Inc. $BIIB
September 8 at 5:04 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-saudi-central-bank-increases-stock-holdings-in-biogen-inc-biib-2026-09-08/
Amundi Purchases 726,004 Shares of Biogen Inc. $BIIB
September 8 at 3:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-amundi-purchases-726004-shares-of-biogen-inc-biib-2026-09-08/
Exelixis (EXEL) Up 13.3% Since Last Earnings Report: Can It Continue?
September 6 at 8:26 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/exelixis-exel-13-3-since-153006855.html
This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.
September 6 at 8:26 AM  |  finance.yahoo.comhttps://finance.yahoo.com/m/eaac730d-29cf-3d81-a48f-e7a16642c09d/this-biotech-wins-a-big-fda.html
Nykredit A S Takes Position in Biogen Inc. $BIIB
September 6 at 4:56 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nykredit-a-s-takes-position-in-biogen-inc-biib-2026-09-06/
B. Metzler seel. Sohn & Co. AG Cuts Stake in Biogen Inc. $BIIB
September 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-b-metzler-seel-sohn-co-ag-cuts-stake-in-biogen-inc-biib-2026-09-05/
Stoke And Biogen Unveil Long-Term Zorevunersen Data In Dravet Syndrome
September 4, 2026  |  rttnews.comhttps://www.rttnews.com/3688494/stoke-and-biogen-unveil-long-term-zorevunersen-data-in-dravet-syndrome.aspx
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
September 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/stoke-therapeutics-biogen-present-long-233000907.html
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
September 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/stoke-therapeutics-biogen-present-long-233000592.html
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
September 3, 2026  |  financialpost.comF
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
September 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/03/3356336/0/en/stoke-therapeutics-and-biogen-present-long-term-clinical-data-that-support-the-disease-modifying-potential-of-zorevunersen-an-investigational-medicine-for-the-treatment-of-dravet-s.html
Biogen (BIIB) Brings At Home Weekly Alzheimer’s Injection To U.S. Patients
September 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/biogen-biib-brings-home-weekly-110629509.html
Biogen And Eisai Announce China Approval For Subcutaneous LEQEMBI To Treat Early Alzheimer's Disease
September 3, 2026  |  rttnews.comhttps://www.rttnews.com/3688074/biogen-and-eisai-announce-china-approval-for-subcutaneous-leqembi-to-treat-early-alzheimer-s-disease.aspx
Biogen (BIIB) Stock Could Be 48% Below Fair Value On New Dravet Data
September 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/biogen-biib-stock-could-48-032559262.html
Rep. Kevin Hern Unloads Shares of Biogen Inc. (NASDAQ:BIIB)
September 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/congress-rep-kevin-hern-unloads-shares-of-biogen-inc-nasdaq-biib-2026-09-03/
Eisai and Biogen Announce China Approval of LEQEMBI SC-AI for Initiation Treatment of Early Alzheimer’s Disease
September 2, 2026  |  quiverquant.comQ
LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer's Disease Approved in China
September 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/03/3355628/0/en/leqembi-lecanemab-subcutaneous-formulation-as-an-initiation-treatment-for-early-alzheimer-s-disease-approved-in-china.html
Biogen gains as pipeline updates and fresh Street target hikes buoy sentiment
September 2, 2026  |  quiverquant.comQ
Biogen (NASDAQ:BIIB) Hits New 1-Year High - What's Next?
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-biogen-nasdaq-biib-hits-new-1-year-high-whats-next-2026-09-02/
Biogen’s (BIIB) Immunology Bet Meets A Pricier Balance Sheet
September 2, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/biogen-biib-immunology-bet-meets-074806222.html
Biogen’s (BIIB) Immunology Bet Meets A Pricier Balance Sheet
September 2, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/biogens-biib-immunology-bet-meets-a-pricier-balance-sheet-1826318/
Jupiter Topco LLC Purchases New Position in Biogen Inc. $BIIB
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-jupiter-topco-llc-purchases-new-position-in-biogen-inc-biib-2026-09-02/
Canada's Drug Agency Backs Public Reimbursement Of Eisai, Biogen's LEQEMBI For Early-Alzheimer's
September 1, 2026  |  rttnews.comhttps://www.rttnews.com/3687357/canada-s-drug-agency-backs-public-reimbursement-of-eisai-biogen-s-leqembi-for-early-alzheimer-s.aspx
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the ...
September 1, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/stoke-therapeutics-biogen-announce-presentations-113000584.html
Biogen: 4-year Data Support Potential Disease-modifying Effects Of Zorevunersen
September 1, 2026  |  rttnews.comhttps://www.rttnews.com/3687526/biogen-4-year-data-support-potential-disease-modifying-effects-of-zorevunersen.aspx
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
September 1, 2026  |  financialpost.comF
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
September 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354025/0/en/stoke-therapeutics-and-biogen-announce-presentations-of-clinical-data-from-studies-of-zorevunersen-an-investigational-medicine-for-the-treatment-of-dravet-syndrome-at-the-16th-euro.html
Biogen Inc. $BIIB Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-biogen-inc-biib-shares-sold-by-ubs-am-a-distinct-business-unit-of-ubs-asset-management-americas-llc-2026-09-01/
Public Employees Retirement System of Ohio Purchases New Position in Biogen Inc. $BIIB
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-public-employees-retirement-system-of-ohio-purchases-new-position-in-biogen-inc-biib-2026-09-01/
Empowered Funds LLC Takes $4.74 Million Position in Biogen Inc. $BIIB
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-empowered-funds-llc-takes-474-million-position-in-biogen-inc-biib-2026-09-01/
Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease
August 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/canada-drug-agency-issues-final-233000991.html
Eisai and Biogen Announce Canada’s Drug Agency Final Recommendation Supporting Public Reimbursement of LEQEMBI for Eligible Early Alzheimer’s Disease Patients
August 31, 2026  |  quiverquant.comQ
Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer's Disease
August 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/31/3353756/0/en/canada-s-drug-agency-issues-final-positive-recommendation-supporting-public-reimbursement-of-leqembi-lecanemab-for-early-alzheimer-s-disease.html
Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock Picks
August 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/josh-brown-says-break-ai-134507001.html
Van ECK Associates Corp Has $21.20 Million Stock Holdings in Biogen Inc. $BIIB
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-van-eck-associates-corp-has-2120-million-stock-holdings-in-biogen-inc-biib-2026-08-31/
Canada Pension Plan Investment Board Makes New Investment in Biogen Inc. $BIIB
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-canada-pension-plan-investment-board-makes-new-investment-in-biogen-inc-biib-2026-08-31/
Josh Brown Says ‘Take a Break From AI CapEx World,’ Highlights His 2 Top Healthcare Stock Picks
August 30, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/josh-brown-says-take-a-break-from-ai-capex-world-highlights-his-2-top-healthcare-stock-picks-1822584/
Biogen Inc. $BIIB Shares Acquired by Wellington Management Group LLP
August 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-biogen-inc-biib-shares-acquired-by-wellington-management-group-llp-2026-08-30/
Rakuten Investment Management Inc. Takes Position in Biogen Inc. $BIIB
August 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-rakuten-investment-management-inc-takes-position-in-biogen-inc-biib-2026-08-30/
United Capital Financial Advisors LLC Acquires New Holdings in Biogen Inc. $BIIB
August 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-united-capital-financial-advisors-llc-acquires-new-holdings-in-biogen-inc-biib-2026-08-30/
Corient Private Wealth LP Takes $10.56 Million Position in Biogen Inc. $BIIB
August 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-corient-private-wealth-lp-takes-1056-million-position-in-biogen-inc-biib-2026-08-30/
Biogen Inc. $BIIB Shares Bought by Alyeska Investment Group L.P.
August 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-biogen-inc-biib-shares-bought-by-alyeska-investment-group-lp-2026-08-30/
Nissay Asset Management Corp Japan Buys 155,539 Shares of Biogen Inc. $BIIB
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nissay-asset-management-corp-japan-buys-155539-shares-of-biogen-inc-biib-2026-08-29/
Jefferies Financial Group Inc. Takes $5.93 Million Position in Biogen Inc. $BIIB
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-jefferies-financial-group-inc-takes-593-million-position-in-biogen-inc-biib-2026-08-29/
Why Is Biogen (BIIB) Up 6.5% Since Last Earnings Report?
August 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/why-biogen-biib-6-5-153024739.html
140,279 Shares in Biogen Inc. $BIIB Purchased by Palo Alto Investors LP
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-140279-shares-in-biogen-inc-biib-purchased-by-palo-alto-investors-lp-2026-08-28/
The Manufacturers Life Insurance Company Buys New Position in Biogen Inc. $BIIB
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-the-manufacturers-life-insurance-company-buys-new-position-in-biogen-inc-biib-2026-08-28/
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
August 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/fda-nods-lilly-roches-alzheimers-142900628.html

Biogen Media Mentions By Week

Biogen Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIIB
News Sentiment
▼
1.02

0.76
▲
Average
Healthcare
News Sentiment

Biogen News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIIB Articles
This Week
▼
24

12
▲
BIIB Articles
Average Week

Biogen Trends on MarketBeat

This week vs. last week
New Followers
2
+100%
Searches
3
-25%
Page Views
4,471
-1%
Get Biogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Biogen dated 9/8/2026.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel